Resistance to targeted therapies in lymphomas / Ana C. Xavier, Mitchell S. Cairo, editors.
Xavier, Ana C.; Cairo, Mitchell S., 1950-
2019
RC280.L9
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Resistance to targeted therapies in lymphomas / Ana C. Xavier, Mitchell S. Cairo, editors.
ISBN 9783030244248 (electronic book)
3030244245 (electronic book)
DOI https://doi.org/10.1007/978-3-030-24
Publication Details Cham : Springer, 2019.
Language English
Description 1 online resource (220 pages).
Item Number 10.1007/978-3-030-24
Call Number RC280.L9
Dewey Decimal Classification 616.99446
Summary This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs. Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.
Bibliography, etc. Note Includes bibliographical references and index.
Access Note Access limited to authorized users.
Source of Description Online resource; title from PDF title page (SpringerLink, viewed September 25, 2019).
Added Author Xavier, Ana C.
Cairo, Mitchell S., 1950-
Series Resistance to targeted anti-cancer therapeutics ; v. 21.
Available in Other Form Resistance to Targeted Therapies in Lymphomas
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Mechanisms of Glucocorticoid Response and Resistance in Lymphoid Malignancies
Resistance to Monoclonal Antibody Therapeutics in Lymphoma
Resistance to Antibody-Drug Conjugate
Resistance to Proteasome Inhibitor Therapy in Non-Hodgkin Lymphoma
Resistance to Histone Deacetylase Inhibitors in the Treatment of Lymphoma
Resistance to Brutons Tyrosine Kinase Signaling Pathway Targeted Therapies
Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs
Resistance to Bispecific T-cell Engagers and Bispecific Antibodies
Resistance to Chimeric antigen receptor T-cell therapy
Index.

Browse Subjects

Show more subjects...

Statistics

from
to
Export